TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8610716

Group type: EXPERIMENTAL
Intervention: Ipratropium bromide (500 micrograms) + albuterol (2.5 mg)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Placebo + albuterol (2.5 mg)
Number of subjects: 195
Study: 1826567

Group type: EXPERIMENTAL
Intervention: Low-dose intradermal recombinant-derived hepatitis B vaccine (1.0 or 1.5 microgram)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Standard intramuscular dose of hepatitis B vaccine
Number of subjects: 132
Study: 7080491

Group type: EXPERIMENTAL
Intervention: 10 mg bemetizide, 20 mg triamterene, 20 mg dihydralazine and 20 mg bupranolol (multiple dose regimen)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: 10 mg bemetizide, 20 mg triamterene, 20 mg dihydralazine and 20 mg bupranolol (single dose regimen)
Number of subjects: 14
Study: 30401688

Group type: EXPERIMENTAL
Intervention: Sunitinib
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286

Group type: COMPARATOR
Intervention: Combined (sunitinib plus placebo)
Number of subjects: 286
Study: 28120351

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus applied twice daily for 3 weeks
Number of subjects: 50

Group type: COMPARATOR
Intervention: Topical clotrimazole applied twice daily for 3 weeks
Number of subjects: 50
Study: 25282071

Group type: EXPERIMENTAL
Intervention: Exparel (liposomal bupivacaine)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Femoral nerve block (FNB)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Exparel
Number of subjects: 80
Study: 23876536

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 57

Group type: COMPARATOR
Intervention: Physical exercise
Number of subjects: 57

Group type: COMPARATOR
Intervention: Both diet and physical exercise
Number of subjects: 57
Study: 21804410

Group type: EXPERIMENTAL
Intervention: Surgical treatment with open reduction and internal fixation using an angular stable plate and cerclages, with physical therapy starting on the third postoperative day.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conservative closed treatment including closed reduction if displacement exceeded 50% of the diaphyseal diameter, with physical therapy starting on the fifteenth postoperative day.
Number of subjects: 50
Study: 19299806

Group type: EXPERIMENTAL
Intervention: Extended-duration continuous femoral nerve block (ropivacaine 0.2%)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 50
Study: 18001477

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 2746

Group type: COMPARATOR
Intervention: Control group (no NAC)
Number of subjects: 2746
Study: 15191260

Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 9
Study: 12215319

Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 9650546

Group type: EXPERIMENTAL
Intervention: Tramadol 100 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Codeine 60 mg
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Aspirin (ASA) 650 mg with codeine 60 mg
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 7648762

Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 10
Study: 2711990

Group type: EXPERIMENTAL
Intervention: Nicardipine 10 mg administered 3 times daily
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Nicardipine 20 mg administered 3 times daily
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Nicardipine 30 mg administered 3 times daily
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study: 186224

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg twice daily)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31474339

Group type: EXPERIMENTAL
Intervention: Detomidine gel (40 μg kg‐1) intravaginally (treatment IVG)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Detomidine hydrochloride (10 μg kg‐1) intravenously (treatment IV)
Number of subjects: 6
Study: 28462683

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy plus intensive medical therapy
Number of subjects: 2480

Group type: EXPERIMENTAL
Intervention: Carotid stenting plus intensive medical therapy
Number of subjects: 2480

Group type: COMPARATOR
Intervention: Intensive medical therapy alone
Number of subjects: 2480
Study: 25946465

Group type: EXPERIMENTAL
Intervention: Internet-based curriculum with cell phone reminders (IT)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Nutritional counselling sessions (sLMP)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care visits (Control)
Number of subjects: 48
Study: 23980580

Group type: EXPERIMENTAL
Intervention: BL Group (bupivacaine-lidocaine)
Number of subjects: 93

Group type: COMPARATOR
Intervention: LIA Group (local infiltration anaesthesia)
Number of subjects: 93
Study: 21872138

Group type: EXPERIMENTAL
Intervention: Nebivolol (10 mg/d)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Carvedilol (50 mg/d)
Number of subjects: 160
Study: 18996423

Group type: EXPERIMENTAL
Intervention: Redesigned immunization card and center-based education
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 1500
Study: 16053592

Group type: EXPERIMENTAL
Intervention: Hospital-at-home care
Number of subjects: 285

Group type: COMPARATOR
Intervention: Standard inpatient hospital care
Number of subjects: 285
Study: 11974642

Group type: EXPERIMENTAL
Intervention: Intervention condition
Number of subjects: 3104

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 3104
Study: 9860382

Group type: EXPERIMENTAL
Intervention: Hands-on classroom experience with low-fat foods
Number of subjects: 0

Group type: COMPARATOR
Intervention: No classroom experience (Control)
Number of subjects: 0
Study: 7637536

Group type: EXPERIMENTAL
Intervention: Glycerol ingestion (2.9 to 3.1 g/kg/d) with large volume of fluid (39.2 or 51.1 ml/kg/d)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluid intake without glycerol
Number of subjects: 0
Study: 2497890

Group type: EXPERIMENTAL
Intervention: Latex agglutination test specific for serotype of pneumococcal antigen
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (102 children without pneumonia)
Number of subjects: 101
Study: 576817

Group type: EXPERIMENTAL
Intervention: Standard tablet formulation (5 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustained-release capsule formulation (20 mg)
Number of subjects: 0
Study: 30522504

Group type: EXPERIMENTAL
Intervention: Thread-embedding acupuncture (TEA) with polydioxanone thread at 14 fixed acupoints, treatment once a week for 4 sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham TEA with a sham device (thread removed), treatment once a week for 4 sessions
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thread-embedding acupuncture (TEA)
Number of subjects: 50
Study: 27400005

Group type: EXPERIMENTAL
Intervention: 50 mg oral sildenafil citrate every 8 hours
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23431960

Group type: EXPERIMENTAL
Intervention: Cylindrical implants (Group A)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Conical/cylindrical implants (Group B)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Both implant types
Number of subjects: 76
Study: 22005217

Group type: EXPERIMENTAL
Intervention: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1
Number of subjects: 324

Group type: COMPARATOR
Intervention: Palonosetron 0.25 mg IV plus dexamethasone 8 mg IV on day 1 followed by oral dexamethasone 8 mg on days 2 and 3
Number of subjects: 324
Study: 21063118

Group type: EXPERIMENTAL
Intervention: Candesartan 8 mg once daily for 3-6 weeks before cardioversion and 16 mg once daily for 6 months after cardioversion
Number of subjects: 98

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study: 19036172

Group type: EXPERIMENTAL
Intervention: M-inflated trials under the random effects model
Number of subjects: 157

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 157
Study: 15522993

Group type: EXPERIMENTAL
Intervention: Lipid + heparin emulsion
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 7
Study: 11823085

Group type: EXPERIMENTAL
Intervention: Angiotensin receptor blockers (ARBs)
Number of subjects: 12469

Group type: COMPARATOR
Intervention: Combination therapy of ARBs and ACEIs
Number of subjects: 12469
Study: 10099031

Group type: EXPERIMENTAL
Intervention: Superior oblique tendon resection only (n = 14)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Superior oblique tendon resection or inferior oblique recession (n = 181)
Number of subjects: 195
Study: 8087727

Group type: EXPERIMENTAL
Intervention: Saizen (0.2 IU/kg sc tiw)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Genotropin (0.1 IU/kg sc qd)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Humatrope (0.1 IU/kg sc qd)
Number of subjects: 15
Study: 2678858

Group type: EXPERIMENTAL
Intervention: Short-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Number of subjects: 750

Group type: COMPARATOR
Intervention: Long-term antibiotic prophylaxis (cefotaxime for biliary or gastric, gentamicin/metronidazole for colorectal)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Patients with preoperative scores less than 5
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Patients with preoperative scores greater than or equal to 5
Number of subjects: 750
Study: 1093498

Group type: EXPERIMENTAL
Intervention: Pentaeritritol administered for 4 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Dipridamol
Number of subjects: 24
Study: 30772849

Group type: EXPERIMENTAL
Intervention: Anakinra in addition to intravenous corticosteroid treatment
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo in addition to intravenous corticosteroid treatment
Number of subjects: 214
Study: 28380315

Group type: EXPERIMENTAL
Intervention: Reduced-Intensity Conditioning (RIC)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Myeloablative Conditioning (MAC)
Number of subjects: 272
Study: 26364528

Group type: EXPERIMENTAL
Intervention: Motivational interviewing self-management program (12-week program: 8 weeks group motivational interviewing and education, 4 weeks individual motivational interviewing on the phone)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 42
Study: 23376004

Group type: EXPERIMENTAL
Intervention: LBTM (lansoprazole 30 mg twice daily, bismuth potassium citrate 220 mg twice daily, tetracycline 500 mg 4 times daily, metronidazole 400 mg 4 times daily)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: LBTF (tetracycline 500 mg 3 times daily, furazolidone 100 mg 3 times daily)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: LBAT (amoxicillin 1000 mg 3 times daily, tetracycline 500 mg 4 times daily)
Number of subjects: 424

Group type: EXPERIMENTAL
Intervention: LBAF (amoxicillin 1000 mg 3 times daily, furazolidone 100 mg 3 times daily)
Number of subjects: 424

Group type: COMPARATOR
Intervention: Furazolidone-containing regimens (LBTF, LBAF)
Number of subjects: 424

Group type: COMPARATOR
Intervention: LBTM
Number of subjects: 424
Study: 21228087

Group type: EXPERIMENTAL
Intervention: Palliative care patient assessment and advance care planning (ACP) intervention
Number of subjects: 33

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 33
Study: 19709060

Group type: EXPERIMENTAL
Intervention: Moderately rough (tioblasted) titanium implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: Minimally rough machined/turned surfaces
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both implant surfaces (tioblasted and turned)
Number of subjects: 20
Study: 18095528

Group type: EXPERIMENTAL
Intervention: Integration of nurse practitioners (NPs) and a pharmacist into the care team
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Ongoing monitoring at home by nurse practitioners (NPs)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Overall integration of nurse practitioners (NPs) into the multidisciplinary team
Number of subjects: 120
Study: 15154857

Group type: EXPERIMENTAL
Intervention: Chronic daily headache
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Common analgesic use
Number of subjects: 40
Study: 11866419

Group type: EXPERIMENTAL
Intervention: Music therapy (20 minutes of preselected music)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 101
Study: 9516221

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Troglitazone
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Combination of Metformin and Troglitazone
Number of subjects: 29
Study: 7750809

Group type: EXPERIMENTAL
Intervention: Levodopa methyl ester (LDME) 250 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 29274540

Group type: EXPERIMENTAL
Intervention: Moderate aerobic exercise training for 24 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-exercise control group
Number of subjects: 60
Study: 26714658

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 25052227

Group type: COMPARATOR
Intervention: High oleic acid sunflower oil (HOS)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Interesterified palm olein (IPO)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Palm olein (PO)
Number of subjects: 53
Study: 23258457

Group type: EXPERIMENTAL
Intervention: Room-air TCOM measurements
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Breathing 100% oxygen
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Threshold for tissue hypoxia
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Recommended TCOM values for tissue hypoxia
Number of subjects: 32
Study: 20876468

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 150
Study: 18165594

Group type: EXPERIMENTAL
Intervention: Epinephrine 4 microg/mL added to ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL (group RFE)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Ropivacaine 1.8 mg/mL and fentanyl 3 microg/mL without epinephrine (group RF)
Number of subjects: 63
Study: 16087692

Group type: EXPERIMENTAL
Intervention: ESFA programme (experimental group)
Number of subjects: 10751

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10751
Study: 12902321

Group type: EXPERIMENTAL
Intervention: Depletion CHO-loading protocol (D group) with 120-min cycle exercise at 65% VO2 peak followed by 1-min sprints at 120% VO2 peak to exhaustion.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nondepletion CHO-loading protocol (ND group) with 20-min cycle exercise at 65% VO2 peak.
Number of subjects: 25
Study: 11153293

Group type: EXPERIMENTAL
Intervention: Silicone cuff tracheostomy tube
Number of subjects: 12

Group type: COMPARATOR
Intervention: Shiley cuffed tracheostomy tube
Number of subjects: 12
Study: 9326900

Group type: EXPERIMENTAL
Intervention: Mandibular long-bar overdenture supported by 4 implants
Number of subjects: 16

Group type: COMPARATOR
Intervention: Two-implant hybrid overdenture
Number of subjects: 16
Study: 8472518

Group type: EXPERIMENTAL
Intervention: ST-679 (1200 mg per day)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Tolmetin (1200 mg per day)
Number of subjects: 160
Study: 2951801

Group type: EXPERIMENTAL
Intervention: Duovent (200 micrograms fenoterol + 80 micrograms ipratropium bromide)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Carbuterol (200 micrograms active substance)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30744914

Group type: EXPERIMENTAL
Intervention: Intravenous dexketoprofen (50 mg)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Intravenous paracetamol (1000 mg)
Number of subjects: 200
Study: 29356339

Group type: EXPERIMENTAL
Intervention: Active psychoeducational intervention (AP)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Passive psychoeducational intervention (PP)
Number of subjects: 43
Study: 27236813

Group type: EXPERIMENTAL
Intervention: Intelligent Physical Exercise Training (IPET) - 1 hour supervised high intensity training every week for 1 year, plus recommendation for 30 minutes of moderate intensity physical activity 6 days a week during leisure.
Number of subjects: 389

Group type: EXPERIMENTAL
Intervention: Intelligent Physical Exercise Training (IPET) - adherence of ≥70%.
Number of subjects: 389

Group type: COMPARATOR
Intervention: Control group (CG) - no specific intervention mentioned.
Number of subjects: 389
Study: 25224239

Group type: EXPERIMENTAL
Intervention: 5% hypertonic saline (HS)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 3% hypertonic saline (HS)
Number of subjects: 124

Group type: COMPARATOR
Intervention: 0.9% normal saline (NS)
Number of subjects: 124
Study: 22986277

Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Supportive Interviews (SI)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No Treatment (NT)
Number of subjects: 83
Study: 20516223

Group type: EXPERIMENTAL
Intervention: Spaced practice
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Massed practice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial study trial
Number of subjects: 0
Study: 18021599

Group type: EXPERIMENTAL
Intervention: Moisturizers with MDBGN at 0.03% w/w
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moisturizers without MDBGN
Number of subjects: 38
Study: 16095961

Group type: EXPERIMENTAL
Intervention: Secure messaging system
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard care without access to messaging system
Number of subjects: 200
Study: 12429074

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Levonorgestrel intrauterine system (LNG‐IUS) with estrogen
Number of subjects: 0
Study: 10513351

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (200 micrograms/dose q.i.d.)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Budesonide (200 micrograms/dose q.i.d.)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate
Number of subjects: 32
Study: 7561195

Group type: EXPERIMENTAL
Intervention: Peru-15 vaccine (2 x 10^8 cfu)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 11
Study: 2324896

Group type: EXPERIMENTAL
Intervention: L-ascorbic acid (AA) 284 mumol (50 mg) twice daily
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (without AA)
Number of subjects: 6
Study: 400464

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31108273

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 18556
Study: 27322609

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 160
Study: 25918644

Group type: EXPERIMENTAL
Intervention: 17-week weight loss program followed by a one-year maintenance program
Number of subjects: 201

Group type: COMPARATOR
Intervention: 17-week weight loss program without subsequent maintenance intervention
Number of subjects: 201
Study: 24238346

Group type: EXPERIMENTAL
Intervention: 6-week minimally guided web-based self-help program
Number of subjects: 260

Group type: COMPARATOR
Intervention: Online psychoeducation program on depression
Number of subjects: 260
Study: 21035909

Group type: EXPERIMENTAL
Intervention: Argon plasma coagulation (APC) tonsillectomy, n = 109
Number of subjects: 218

Group type: COMPARATOR
Intervention: Conventional tonsillectomy, n = 109
Number of subjects: 218
Study: 19584830

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution
Number of subjects: 772

Group type: COMPARATOR
Intervention: PEG‐EA regimen
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (split-dose)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution (1-day preparation)
Number of subjects: 772

Group type: COMPARATOR
Intervention: PEG‐EA (1-day preparation)
Number of subjects: 772

Group type: EXPERIMENTAL
Intervention: Oral sulfate solution and PEG‐EA
Number of subjects: 772
Study: 16905562

Group type: EXPERIMENTAL
Intervention: Clinical pathway implementation (post-implementation group)
Number of subjects: 267

Group type: COMPARATOR
Intervention: Pre-implementation control group
Number of subjects: 267
Study: 15136366

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 25 mg/d plus aspirin 100 mg/d
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo plus aspirin 100 mg/d
Number of subjects: 34
Study: 11295882

Group type: EXPERIMENTAL
Intervention: Blood-brain ratios (BBR) of phenylalanine (Phe) measured by 1H magnetic resonance spectroscopy (1H‐MRS)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Blood Phe values
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Long-term dietary control
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Fluctuation of blood Phe values during treatment
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: High blood and brain Phe concentrations
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: BBR values, intelligence quotient, and MRI grade
Number of subjects: 17
Study: 10920905

Group type: EXPERIMENTAL
Intervention: N-CWS
Number of subjects: 45

Group type: COMPARATOR
Intervention: MMC
Number of subjects: 45
Study: 18476202

Group type: EXPERIMENTAL
Intervention: Electrocautery subcutaneous incision
Number of subjects: 380

Group type: COMPARATOR
Intervention: Scalpel subcutaneous incision
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Infection
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Risk factors
Number of subjects: 380
Study: 3826196

Group type: EXPERIMENTAL
Intervention: Uterine activity monitor
Number of subjects: 67

Group type: COMPARATOR
Intervention: Palpation (Control)
Number of subjects: 67
Study: 31640847

Group type: EXPERIMENTAL
Intervention: Ankle plantar-flexed during static stretching
Number of subjects: 14

Group type: COMPARATOR
Intervention: Ankle dorsiflexed during static stretching
Number of subjects: 14